Y. Ghazi

Safety and Efficacy of Extended Bevacizumab Therapy in Elderly (≥70 Years) Versus Younger Patients Treated for Newly Diagnosed Ovarian Cancer in the International ROSiA Study

A. Oza, A. Cardona, N. Colombo, 2018, International Journal of Gynecologic Cancer.

International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)

J. Le Heuzey, J. Healey, J. Camm, 2019, Thrombosis Journal.

A multidisciplinary approach to oncology trials: Study conduct of the ANTHALYA trial.

R. Rouzier, F. Joly, Y. Ghazi, 2018, Contemporary clinical trials.

A randomized, open-label, phase II study assessing the efficacy and the safety of bevacizumab in neoadjuvant therapy in patients with FIGO stage IIIc/IV ovarian, tubal, or peritoneal adenocarcinoma, initially unresectable.

R. Rouzier, F. Guyon, P. Colombo, 2014 .

Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial.

R. Rouzier, P. Colombo, E. Kalbacher, 2017, European journal of cancer.

Abstract OT1-01-01: IMpassion131: A phase III study comparing 1L atezolizumab with paclitaxel vs placebo with paclitaxel in treatment-naive patients with inoperable locally advanced or metastatic triple negative breast cancer (TNBC)

A. Schneeweiss, Bing-he Xu, F. André, 2018 .